Patent ID: 11905274
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 30:
31. The compound according to claim 9, or a pharmaceutically acceptable salt, ester, stereoisomer, polymorph, solvate, N-oxide, isotopically labeled compound, or prodrug thereof, wherein Y and Z, at each occurrence, are each independently selected from the group consisting of a single bond; NR10; O; S; and methylene, ethylene, —CH2—O—, —O—CH2—, —CH2—S—, —S—CH2—, —CH2—NR10—, —NR10—CH2—, —CH═CH—, —CH═N— or —N═CH—, which are optionally substituted by 1, 2, 3 or more groups selected from the group consisting of halogen, OH, —NR11R12, cyano, nitro, C1-6 alkyl, C1-6 alkyl-O—, epoxy and oxo; and
wherein R10 is selected from the group consisting of H, C1-6 alkyl, C3-10 cyclic hydrocarbyl group, —OR11, —SR11, —C(═O)OR11 and —NR11R12; and
R11 and R12, at each occurrence, are each independently selected from the group consisting of H, C1-6 alkyl, C3-10 cyclic hydrocarbyl group, 3- to 10-membered heterocyclic group, C6-10 aryl, 5- to 14-membered heteroaryl and C6-12 aralkyl.